Literature DB >> 2858836

Muscle relaxant action of excitatory amino acid antagonists.

L Turski, M Schwarz, W A Turski, T Klockgether, K H Sontag, J F Collins.   

Abstract

Antagonists of neuronal excitation induced by dicarboxylic amino acids were tested in genetically spastic rats of the Han-Wistar strain. These animals exhibit an increased muscle tone which can be measured as a spontaneous tonic activity in the electromyogram of the gastrocnemius-soleus muscle. Compounds that block excitation due to N-methyl-D-aspartic acid reduced the spontaneous activity measured in the electromyogram in a dose-related manner. The most potent compounds, 2-amino-7-phosphonoheptanoic and kynurenic acids were effective muscle relaxants when given either intraperitoneally or intracerebroventricularly. 2-Amino-5-phosphonopentanoic acid possessed much weaker muscle relaxant activity, while L-glutamic acid diethylester was inactive by either route. The results suggest that blockade of N-methyl-D-aspartic acid receptors results in a myorelaxant effect. Specific antagonists of excitation at N-methyl-D-aspartic acid receptors may provide a new class of muscle relaxants.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858836     DOI: 10.1016/0304-3940(85)90558-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli.

Authors:  P M Headley; C G Parsons; D C West
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

2.  Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice.

Authors:  S Liljequist
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Trends in the pathophysiology and pharmacotherapy of spasticity.

Authors:  J Noth
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

4.  Intra-ventricular infusion of the NMDA antagonist AP5 impairs performance on a non-spatial operant DRL task in the rat.

Authors:  J Tonkiss; R G Morris; J N Rawlins
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 5.  A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex.

Authors:  P L Wood; T S Rao; S Iyengar; T Lanthorn; J Monahan; A Cordi; E Sun; M Vazquez; N Gray; P Contreras
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

6.  NMDA receptor antagonists can enhance or impair learning performance in animals.

Authors:  C Mondadori; L Weiskrantz; H Buerki; F Petschke; G E Fagg
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

7.  Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?

Authors:  D N Stephens; B S Meldrum; R Weidmann; C Schneider; M Grützner
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice.

Authors:  M E Nevins; S A Nash; P M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  The effect of centrally acting myorelaxants on NMDA receptor-mediated synaptic transmission in the immature rat spinal cord in vitro.

Authors:  R J Siarey; S K Long; R H Evans
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

10.  Effects of competitive and non-competitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle.

Authors:  J L Wiley; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.